Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2008
12/02/2008US7459473 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth
12/02/2008US7459470 For example, N-(Isoquinolin-3-yl)-2-(4-pyridylmethyl)aminobenzoic acid amide-N-oxide; use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, such as psoriasis, arthritis, hemangioma, angiofibroma, eye diseases, cirrhosis of the liver
12/02/2008US7459466 Antiinflammatory agents; autoimmune diseases; anticancer agents
12/02/2008US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism
12/02/2008US7459455 Pyrimidine compounds
12/02/2008US7459453 Pyridazin-3(2H)-one derivatives as PDE4 inhibitors
12/02/2008US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells
12/02/2008US7459272 In order to produce lytic infections in pathogenic bacteria to prevent infection, especially post-surgery
12/02/2008US7459171 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area of penetrants; drug delivery
12/02/2008US7459158 Can be used to vaccinate a mammal against specific self or non-self antigens
12/02/2008CA2396111C Substances for use in treating psoriasis
12/02/2008CA2394230C Novel stromelysin inhibitors
12/02/2008CA2361841C Mevinolin derivatives
12/02/2008CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
12/02/2008CA2153604C Formulations containing esculoside and the use thereof in the pharmaceutical and cosmetic fields
11/2008
11/27/2008WO2008144352A1 Threitol phosphates, salts thereof and methods of use
11/27/2008WO2008143545A1 Agent for stimulating lymphatic drainage
11/27/2008WO2008143240A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
11/27/2008WO2008143239A1 Crystalline micropowder particles
11/27/2008WO2008143182A1 Composition containing licorice-derived polyphenol
11/27/2008WO2008143145A1 Skin-moisturizing effect evaluation method, and screening method for moisturizing substance by using the evaluation method
11/27/2008WO2008142397A1 Serine protease inhibitors for use in the treatment of bacterial infections
11/27/2008WO2008142147A1 Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and asparagine, and use thereof in the treatment of atopic dermatitis
11/27/2008WO2008142031A1 P38alpha as a therapeutic target in bladder carcinoma
11/27/2008WO2008101693A3 Cosmetic and pharmaceutical applications of n-acylated amino acids and structurally related compounds
11/27/2008WO2008101692A3 Cosmetic and pharmaceutical applications of n-acetylhydroxyproline
11/27/2008WO2008094910A3 Hyaluronate compositions
11/27/2008WO2008043944A3 Use of an active ingredient derived from flax that acts on the papillary dermis, for its anti-ageing action
11/27/2008US20080293962 Novel compounds of the N-acylamino amide family compositions comprising them and uses thereof
11/27/2008US20080293818 Regulator of Physiological Function of Ghrelin and Use Thereof
11/27/2008US20080293817 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
11/27/2008US20080293816 Use of 2,5-Dihydroxybenzenesulphonic Acid in the Production of Medicaments for the Treatment of Angiodependent Diseases Such as Cancer and Psoriasis
11/27/2008US20080293811 External preparation for the the skin
11/27/2008US20080293807 Skin Cosmetic and Wrinkle-Reducing Agent
11/27/2008US20080293803 Melatonin daily dosage units
11/27/2008US20080293748 Thioxanthine Derivatives as Myeloperoxidase Inhibitors
11/27/2008US20080293700 Compositions and Methods Relating to Novel Compounds and Targets Thereof
11/27/2008US20080293681 Sprayable pharmaceutical compositions comprising a vitamin d derivative and an oily phase
11/27/2008US20080293673 N-acetyglucosamine derivatives and use thereof
11/27/2008US20080293669 Composition Containing Beta-Glucan, Method of Producing the Same and Foods, Drinks or Skin Moisturizers Containing the Composition
11/27/2008US20080293660 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/27/2008US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
11/27/2008US20080293657 Modulation of the expression of stat-1-dependent genes
11/27/2008US20080292734 Compositions and methods for treatment of dermal scarring and wrinkling
11/27/2008US20080292728 Cosmetic composition
11/27/2008US20080292717 Highly Stable Aqueous Solution, Electrode with Nanocoating for Preparing the Solution and Method for Making this Electrode
11/27/2008US20080292689 Method for inhibiting free radicals
11/27/2008US20080292682 Method for treating allergic dermatitis
11/27/2008US20080292651 Skin firming and lifting compositions and methods of use
11/27/2008US20080292624 Method of detecting and treating tuberous sclerosis complex associated disorders
11/27/2008US20080292615 Diagnosis and treatment of disease
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292568 3-Deoxyglucosone and skin
11/27/2008US20080292561 Pyrazolo-Pyrimidine Derivatives as Anti-Inflammatory Agents
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008DE10251709B4 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3
11/27/2008DE102007024384A1 Kosmetische und dermatologische Zusammensetzungen gegen trockene Haut Cosmetic and dermatological compositions for dry skin
11/27/2008DE102007024377A1 Antiseptic cosmetic skin cleansing and/or care composition, useful for combating bacterial, fungal and/or viral skin infections, contains photoactive metal oxide, e.g. titanium dioxide
11/27/2008DE102007024138A1 Kosmetisches Hautreinigungsmittel Cosmetic skin cleanser
11/27/2008CA2687955A1 Crystalline micropowder particles
11/27/2008CA2687558A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
11/27/2008CA2687545A1 Agent for stimulating lymphatic drainage
11/27/2008CA2687324A1 Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and asparagine, and use thereof in the treatment of atopic dermatitis
11/27/2008CA2686421A1 P38.alpha. as a therapeutic target in bladder carcinoma
11/27/2008CA2684604A1 Methods and compositions for treating skin conditions
11/27/2008CA2684150A1 Induction of a physiological dispersion response in bacterial cells in a biofilm
11/26/2008EP1994941A2 Medicine containing at least one oxidised protein
11/26/2008EP1993672A2 Na/k-atpase ligand
11/26/2008EP1993566A1 Protease inhibitor for wound treatment
11/26/2008EP1993544A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain
11/26/2008EP1993525A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain
11/26/2008EP1993383A2 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation
11/26/2008EP1689349A4 A method of inducing melanogenesis in humans with mc1r variant alleles
11/26/2008EP1496914B1 (20S)-1alpha-HYDROXY-2alpha-METHYL AND 2beta-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
11/26/2008EP1473300B1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases
11/26/2008EP1414455B1 Isoquinoline inhibitors of p38
11/26/2008EP1337517B1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
11/26/2008EP1330452B1 Pyrazine derivatives as modulators of tyrosine kinases
11/26/2008EP1264548B1 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy
11/26/2008EP1234574B1 Hair growth stimulant
11/26/2008EP0969875B1 Naked dna-mediated gene transfer into medullary motor neurons
11/26/2008CN101312745A Therapeutic agent for skin or skin repair-promoting agent comprising ghrelin, derivative thereof or substance capable of acting on ghs-r1a as active ingredient
11/26/2008CN101312739A Therapeutic agent for skin or skin repair-promoting agent comprising des-acylghrelin or derivative thereof as active ingredient
11/26/2008CN101310757A Plaster for treating tinea corporis and tinea on manus and pedes
11/26/2008CN101310748A Ointment for treating empyrosis
11/26/2008CN101310741A Traditional Chinese medicine composition for treating burns and scalds
11/26/2008CN101310727A Alcohol-containing chlorhexidine iodine disinfectant and preparation method thereof
11/26/2008CN101310726A Alcohol-containing polyhexamethylguanidine iodine disinfectant and preparation method thereof
11/26/2008CN100436578C Modulation of the transcription of pro-inflammatory gene products
11/26/2008CN100436462C Reaction method of biological alkali, reaction product and use thereof
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436442C Method for the production of flavonoid-containing compositions and use thereof
11/26/2008CN100436439C Dimeric isoflavones
11/26/2008CN100436427C Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
11/26/2008CN100435822C Oral liquor for clearing wart
11/26/2008CN100435808C Chinese medicine for treating dermatosis and tumor
11/26/2008CN100435807C Pharmaceutical gel composition
11/26/2008CN100435801C External use medicine for treating dermatosis and its preparing method
11/26/2008CN100435783C Orally administered composition containing fat soluble ingredient of red sage root
11/26/2008CN100435775C Use of 3-position cyclosporin derivatives for hair growth
1 ... 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 ... 1065